Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, participated in U.S. Food and Drug Administration (FDA) Vaccines and Related...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, participated in the U.S. Food and Drug Administration...
